Patient Versus Physician Valuation of Durable Survival Gains: Implications for Value Framework Assessments

Patients place a high value on therapies that provide a chance of durable or “tail-of-the-curve” survival, whereas physicians do not. Value frameworks should incorporate measures of tail-of-the-curve survival gains into their methodologies.